Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis

Journal of Perinatology

Volumn 25, Issue 5, 2005, Pages 336-340

  Doyle, Nora M ^a,d   Gardner, Michael O ^b   Wells, Lorraine ^c   Qualls, Clifford ^c   Papile, Lu Ann ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; INDOMETACIN; MAGNESIUM SULFATE;

ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MECHANISM; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOMES RESEARCH; PATENT DUCTUS ARTERIOSUS; PREECLAMPSIA; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; TOCOLYSIS; VERY LOW BIRTH WEIGHT;

CAUSE OF DEATH; COHORT STUDIES; CRITICAL CARE; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, NECROTIZING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOCOLYSIS;

EID: 18444414881     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211256     Document Type: Article

References (25)

1. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90.
2. Goldenberg RL, Rouse DJ. Prevention of preterm birth. N Engl J Med 1998; 339:313-20.
3. Robertson PA, Snickerman SH, Laros Jr RK, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol 1992;166 (6 Part 1):1629-41 discussion 1641-5.
4. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap III LC. Williams Obstetrics 21st ed. Norwalk Connecticut: Appleton & Lange; 1993.
5. Kimberlin DF, Hauth JC, Owen J, et al. Indicated versus spontaneous preterm delivery: an evaluation of neonatal morbidity among infants weighing ≤ 1000 grams at birth. Am J Obstet Gynecol 1999;180:683-9.
6. Iams JD. Preterm labor. Clin Obstet Gynecol 1995;38:673.
7. Hill WC. Risks and complications of tocolysis. Clin Obstet Gynecol 1995;38: 725-745.
8. Gamissans O, Balasch J. Prostaglandin synthetase inhibitors in the treatment of preterm birth. In: Fuchs A, Fuchs F, Stubblefield PG, editors. Preterm Birth-Causes, Prevention, and Management. 2nd ed. New York: McGraw-Hill; 1993 p. 309-32.
9. Gordon MC, Samuels P. Indomethacin. Clin Obstet Gynecol 1995;38: 697-705.
10. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin Part 1. J Perinatal Med 1984;12:19-29.
11. Niebyl JR, Blake DA, White RD, et al. The inhibition of preterm labor with indomethacin. Am J Obstet Gynecol 1980;136:1014-9.
12. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993;169:97-102.
13. Kurki T, Eronen M, Lumme R, Ylikorkata O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol 1991;78:1093-7.
14. Katz Z, Lancet M, Mogliner BM, Feigl A, Ben HH. Treatment of premature labor contractions with combined Ritodrine and indomethacin. Int J Gynaecol Obstet 1983;21:337-42.
15. Higby K, Xenakis E, Pauerstein C. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59.
16. Merrill JD, Clyman RI, Norton ME. Indomethacin as a tocolytic agent: the controversy continues. J Pediatrics 1994;124:734-5.
17. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
18. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low birth weight neonate. Am J Obstet Gynecol 1994;170:102-6.
19. Gardner MO, Owen J, Skelly S, Hauth JC. Preterm delivery after indomethacin: a risk factor for neonatal complications. J Reprod Med 1996; 41:903-6.
20. Fanaroff AA, Wright LL, Stevenson DK, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am J Obstet Gynecol 1995;173:1423-31.
21. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
22. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1,500 grams. J Pediatr 1978;92:529-34.
23. Vermillion St, Newman RB. Neonatal complications associated with recent indomethacin tocolysis in preterm infants. Am J Obstet Gynecol 1999;181:1083-6.
24. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Duncan CC, Makuch RW. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795-800.
25. Gardner MO, Papile LA, Wright LL. Antenatal corticosteroids in pregnancies complicated by preterm premature rupture of membranes. Obstet Gynecol 1997;90:851-3.